N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide

C13H17FN4O3 — CID 155915789

IUPACN-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide
SMILESO=C(Nc1nc(N2CCOCC2)ncc1F)C1CCOC1
InChIInChI=1S/C13H17FN4O3/c14-10-7-15-13(18-2-5-20-6-3-18)17-11(10)16-12(19)9-1-4-21-8-9/h7,9H,1-6,8H2,(H,15,16,17,19)
InChIKeyBYAJQZVIUPFYOM-UHFFFAOYSA-N
MW296.30 g/mol
LogP0.43
Rot. Bonds3

About N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide

N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide (PubChem CID 155915789) has the molecular formula C13H17FN4O3 and a molecular weight of 296.30 g/mol. Its IUPAC name is N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide.

Molecular Properties

Compound NameN-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide
PubChem CID155915789
Molecular FormulaC13H17FN4O3
Molecular Weight296.30 g/mol
Exact Mass296.13
IUPAC NameN-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide
SMILESO=C(Nc1nc(N2CCOCC2)ncc1F)C1CCOC1
InChIInChI=1S/C13H17FN4O3/c14-10-7-15-13(18-2-5-20-6-3-18)17-11(10)16-12(19)9-1-4-21-8-9/h7,9H,1-6,8H2,(H,15,16,17,19)
InChIKeyBYAJQZVIUPFYOM-UHFFFAOYSA-N
XLogP0.43
TPSA76.58 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500296.30
LogP ≤ 50.43
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(3S)-N-[1-(4-fluorophenyl)-4-morpholin-4-ylindazol-3-yl]oxolane-3-carboxamide
CID 95894266
1-(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)-N-methylpyrrolidine-3-carboxamide
CID 50962192
N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)-5-methyl-3-phenyl-1,2-oxazole-4-carboxamide
CID 155912706
N-[2-(2,4,5-trimethylimidazol-1-yl)pyrimidin-5-yl]oxolane-3-carboxamide
CID 122301376
N-[2-[4-[3-(3,5-difluorophenyl)-3,4-dihydropyrazole-2-carbonyl]piperazin-1-yl]-5-fluoropyrimidin-4-yl]cyclopentanecarboxamide
CID 166747350
N-[2-(4-methylpiperazin-1-yl)pyrimidin-5-yl]oxane-4-carboxamide
CID 122299154
N-[[1-(5-bromopyrimidin-2-yl)-4-fluoropiperidin-4-yl]methyl]oxolane-3-carboxamide
CID 165432283
4-(5-fluoro-2-piperidin-1-ylpyrimidin-4-yl)morpholine
CID 3631524
[4-(5-methylsulfonyl-2-morpholin-4-ylpyrimidin-4-yl)piperidin-1-yl]-(oxolan-3-yl)methanone
CID 46962303
N-[6-(4-morpholin-4-ylphenyl)imidazo[1,2-a]pyrazin-3-yl]oxolane-3-carboxamide
CID 126471371
(3R)-N-(2-morpholin-4-yl-1,3-benzothiazol-6-yl)oxolane-3-carboxamide
CID 95272006
N-[(4-morpholin-4-ylpyrimidin-2-yl)methyl]oxolane-3-carboxamide
CID 122318827

Frequently Asked Questions

What is the IUPAC name of N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide?
The IUPAC name of N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide (CID 155915789) is N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide.
What is the SMILES notation for N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide?
The canonical SMILES for N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide is O=C(Nc1nc(N2CCOCC2)ncc1F)C1CCOC1.
What is the InChIKey of N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide?
The InChIKey is BYAJQZVIUPFYOM-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H17FN4O3/c14-10-7-15-13(18-2-5-20-6-3-18)17-11(10)16-12(19)9-1-4-21-8-9/h7,9H,1-6,8H2,(H,15,16,17,19).
What are the key properties of N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide?
N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide has a molecular weight of 296.30 g/mol, XLogP of 0.43, 3 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-fluoro-2-morpholin-4-ylpyrimidin-4-yl)oxolane-3-carboxamide is sourced from PubChem (CID 155915789), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).